FUM vs. HVO, SCLP, TILS, VSN, MPH, ORPH, OBI, REDX, SBTX, and ETX
Should you be buying Futura Medical stock or one of its competitors? The main competitors of Futura Medical include hVIVO (HVO), Scancell (SCLP), Tiziana Life Sciences (TILS), Verseon (VSN), Mereo BioPharma Group plc (MPH.L) (MPH), Open Orphan (ORPH), Ondine Biomedical (OBI), Redx Pharma (REDX), SkinBioTherapeutics (SBTX), and e-therapeutics (ETX). These companies are all part of the "biotechnology" industry.
Futura Medical vs.
hVIVO (LON:HVO) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation, community ranking and dividends.
Futura Medical received 62 more outperform votes than hVIVO when rated by MarketBeat users. However, 70.06% of users gave hVIVO an outperform vote while only 64.36% of users gave Futura Medical an outperform vote.
hVIVO has higher revenue and earnings than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks.
hVIVO has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Futura Medical has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500.
34.9% of hVIVO shares are owned by institutional investors. Comparatively, 35.7% of Futura Medical shares are owned by institutional investors. 14.0% of hVIVO shares are owned by company insiders. Comparatively, 32.1% of Futura Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
hVIVO has a net margin of 25.96% compared to Futura Medical's net margin of -44.64%. hVIVO's return on equity of 47.93% beat Futura Medical's return on equity.
In the previous week, hVIVO had 1 more articles in the media than Futura Medical. MarketBeat recorded 1 mentions for hVIVO and 0 mentions for Futura Medical. hVIVO's average media sentiment score of 0.75 beat Futura Medical's score of 0.00 indicating that hVIVO is being referred to more favorably in the media.
Summary
hVIVO beats Futura Medical on 12 of the 17 factors compared between the two stocks.
Get Futura Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for FUM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Futura Medical Competitors List
Related Companies and Tools
This page (LON:FUM) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy FUM Stock Free FUM Stock Alerts